Abstract
Mutations in RAS isoforms (KRAS, NRAS, and HRAS) are among the most frequent oncogenic alterations in many cancers, making these proteins high priorit......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
